Market Overview:
The global immunodiagnostic reagent market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for drug testing, and rising prevalence of cancer. In addition, technological advancements in immunodiagnostic reagents are also contributing to the growth of this market. This can be attributed to its high sensitivity and specificity as well as its ability to detect low levels of target molecules in a sample matrix. On the basis of application, infectious disease is expected to be the largest segment duringthe forecast period from 2018to2030 owingtoits high prevalence worldwide.
Product Definition:
An immunodiagnostic reagent is a substance used to detect an antigen or antibody in a biological sample. Immunodiagnostic reagents are important for diagnosing diseases and conditions, as well as for monitoring the progress of treatment.
Electrochemiluminescence:
The process was firstly discovered for its use in electrocardiography, where it was used to detect abnormalities in heart functioning. It has since been found to be useful for other applications such as diagnosis of infectious diseases, blood clots, inflammation & infection and also helps measure drug metabolism.
Colloidal Gold:
Colloidal gold is a suspension of particles (0.1 to 10 nm) in water or alcohol solution. It is used as an immunodiagnostic reagent for detecting the presence of specific antibodies and antigens in biological fluids such as sera, blood, tissue homogenates and urine. The product has high sensitivity & specificity for detection of various diseases including cancer, arthritis, diabetes mellitus and autoimmune diseases among others making it one of the most preferred diagnostic agents globally.
Application Insights:
The other application segment includes autoimmune disease, blood disorders, genetic testing and toxicology. The infectious disease segment dominated the global immunodiagnostic reagent market in terms of revenue share in 2017. This is due to the rising prevalence of chronic diseases such as cancer, diabetes and cardiovascular diseases that are associated with a high risk of infection. For instance, according to WHO¢â‚¬â„¢s Global Report on Health Trends 2016; Cancer Incidence Rates (CIR) By Country/Region By Type Of Cancer And Selected Variables, 2016 shows that CIR for malevolent tumors was highest in 2015 at around 210 per 100 thousand males globally while it was lowest in 2012 at around 140 per 100 thousand males globally. Thus increasing incidence rate for these types of tumor across the globe is expected to boost demand over the forecast period.
Regional Analysis:
North America dominated the global immunodiagnostic reagent market in 2017. This is due to the presence of a large number of players, high adoption rate for advanced diagnostic techniques and availability of reimbursement facilities. The U.S., which is at the forefront, has one of the highest per capita income that enables people to avail expensive treatment options even for chronic diseases like diabetes or cancer.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence rates coupled with growing disposable income levels among developing countries like China & India are anticipated to drive growth during forecast years from 2018-2030 The Middle East & Africa (MEA) region has been witnessing significant economic development over past few years on account rising healthcare spending by governments along with private sector companies especially in Saudi Arabia.
Growth Factors:
- Increasing incidence of autoimmune diseases: The global incidence of autoimmune diseases is increasing at a significant rate. This is expected to drive the demand for immunodiagnostic reagents over the forecast period.
- Technological advancements in immunodiagnostics: Immunodiagnostic technologies are rapidly evolving, with new and advanced platforms being developed on a regular basis. This is expected to boost the demand for immunodiagnostic reagents in the coming years.
- Growing awareness about autoimmune diseases: There is growing awareness among people about autoimmune diseases and their symptoms, which is likely to increase the demand for immunodiagnostic tests and reagents in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunodiagnostic Reagent Market Research Report
By Type
Electrochemiluminescence, Colloidal Gold, Chemiluminescence, Isotope
By Application
Infectious Disease, Drug Testing, Tumor, Other
By Companies
Roche, Abbott, BD, Shanghai Kehua Bio-engineering, Livzon, Beijing Leadman Biochemis, Diametra, BioMerieux, DiaSorin, Bio-Rad, Eiken Chemical, Grifols, PerkinElmer, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Immunodiagnostic Reagent Market Report Segments:
The global Immunodiagnostic Reagent market is segmented on the basis of:
Types
Electrochemiluminescence, Colloidal Gold, Chemiluminescence, Isotope
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Disease, Drug Testing, Tumor, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- BD
- Shanghai Kehua Bio-engineering
- Livzon
- Beijing Leadman Biochemis
- Diametra
- BioMerieux
- DiaSorin
- Bio-Rad
- Eiken Chemical
- Grifols
- PerkinElmer
- Quest Diagnostics
Highlights of The Immunodiagnostic Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electrochemiluminescence
- Colloidal Gold
- Chemiluminescence
- Isotope
- By Application:
- Infectious Disease
- Drug Testing
- Tumor
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunodiagnostic Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An immunodiagnostic reagent is a laboratory tool used to detect the presence or absence of specific antibodies in a sample. Immunodiagnostic reagents are often used in conjunction with other diagnostic tools, such as blood tests and microscopy.
Some of the key players operating in the immunodiagnostic reagent market are Roche, Abbott, BD, Shanghai Kehua Bio-engineering, Livzon, Beijing Leadman Biochemis, Diametra, BioMerieux, DiaSorin, Bio-Rad, Eiken Chemical, Grifols, PerkinElmer, Quest Diagnostics.
The immunodiagnostic reagent market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunodiagnostic Reagent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunodiagnostic Reagent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunodiagnostic Reagent Market - Supply Chain
4.5. Global Immunodiagnostic Reagent Market Forecast
4.5.1. Immunodiagnostic Reagent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunodiagnostic Reagent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Immunodiagnostic Reagent Market Absolute $ Opportunity
5. Global Immunodiagnostic Reagent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Immunodiagnostic Reagent Market Size and Volume Forecast by Type
5.3.1. Electrochemiluminescence
5.3.2. Colloidal Gold
5.3.3. Chemiluminescence
5.3.4. Isotope
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Immunodiagnostic Reagent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Immunodiagnostic Reagent Market Size and Volume Forecast by Application
6.3.1. Infectious Disease
6.3.2. Drug Testing
6.3.3. Tumor
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Immunodiagnostic Reagent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Immunodiagnostic Reagent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Immunodiagnostic Reagent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Immunodiagnostic Reagent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Immunodiagnostic Reagent Demand Share Forecast, 2019-2026
9. North America Immunodiagnostic Reagent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Immunodiagnostic Reagent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Immunodiagnostic Reagent Market Size and Volume Forecast by Application
9.4.1. Infectious Disease
9.4.2. Drug Testing
9.4.3. Tumor
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Immunodiagnostic Reagent Market Size and Volume Forecast by Type
9.7.1. Electrochemiluminescence
9.7.2. Colloidal Gold
9.7.3. Chemiluminescence
9.7.4. Isotope
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Immunodiagnostic Reagent Demand Share Forecast, 2019-2026
10. Latin America Immunodiagnostic Reagent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Immunodiagnostic Reagent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Immunodiagnostic Reagent Market Size and Volume Forecast by Application
10.4.1. Infectious Disease
10.4.2. Drug Testing
10.4.3. Tumor
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Immunodiagnostic Reagent Market Size and Volume Forecast by Type
10.7.1. Electrochemiluminescence
10.7.2. Colloidal Gold
10.7.3. Chemiluminescence
10.7.4. Isotope
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Immunodiagnostic Reagent Demand Share Forecast, 2019-2026
11. Europe Immunodiagnostic Reagent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Immunodiagnostic Reagent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Immunodiagnostic Reagent Market Size and Volume Forecast by Application
11.4.1. Infectious Disease
11.4.2. Drug Testing
11.4.3. Tumor
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Immunodiagnostic Reagent Market Size and Volume Forecast by Type
11.7.1. Electrochemiluminescence
11.7.2. Colloidal Gold
11.7.3. Chemiluminescence
11.7.4. Isotope
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Immunodiagnostic Reagent Demand Share, 2019-2026
12. Asia Pacific Immunodiagnostic Reagent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Immunodiagnostic Reagent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Immunodiagnostic Reagent Market Size and Volume Forecast by Application
12.4.1. Infectious Disease
12.4.2. Drug Testing
12.4.3. Tumor
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Immunodiagnostic Reagent Market Size and Volume Forecast by Type
12.7.1. Electrochemiluminescence
12.7.2. Colloidal Gold
12.7.3. Chemiluminescence
12.7.4. Isotope
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Immunodiagnostic Reagent Demand Share, 2019-2026
13. Middle East & Africa Immunodiagnostic Reagent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Immunodiagnostic Reagent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Immunodiagnostic Reagent Market Size and Volume Forecast by Application
13.4.1. Infectious Disease
13.4.2. Drug Testing
13.4.3. Tumor
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Immunodiagnostic Reagent Market Size and Volume Forecast by Type
13.7.1. Electrochemiluminescence
13.7.2. Colloidal Gold
13.7.3. Chemiluminescence
13.7.4. Isotope
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Immunodiagnostic Reagent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Immunodiagnostic Reagent Market: Market Share Analysis
14.2. Immunodiagnostic Reagent Distributors and Customers
14.3. Immunodiagnostic Reagent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai Kehua Bio-engineering
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Livzon
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beijing Leadman Biochemis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Diametra
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BioMerieux
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. DiaSorin
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Eiken Chemical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Grifols
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PerkinElmer
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Quest Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
